Pharmaceutical Expertise® spoke with Luca Cavazzini, Gross sales & Advertising director at IMA Energetic, a division of IMA Pharma, on the firm’s NEXTEN occasion, which was held in Lake Como, Italy in October 2025, to be taught extra about a number of the challenges dealing with pharmaceutical producers and the way IMA Energetic addresses these challenges. IMA Energetic gives applied sciences for oral strong dose manufacturing, in addition to built-in programs and companies that assist pharmaceutical corporations speed up time-to-market inside a regulatory compliance atmosphere.
PharmTech: In what methods is the drive for sustainability influencing facility design and gear choice/upgrading?
Cavazzini (IMA Energetic): Sustainability has turn into a strategic pillar for pharmaceutical manufacturing, influencing not solely facility layouts but additionally the best way gear is designed and applied. At IMA Energetic, we see sustainability as a mixture of effectivity, resilience, and compliance. This implies integrating energy-efficient programs, compact footprints, modular design, and predictive upkeep to increase machine lifecycle and cut back useful resource consumption.
A transparent instance is DOMINA, our newest pill press. It combines superior management programs with real-time monitoring to reduce power utilization and scrap. Options like Vitality Diary give producers full visibility of consumption, enabling data-driven selections for greener operations. Its modular structure helps gradual funding and reduces downtime, whereas adaptive automation ensures constant high quality with minimal waste.
In the end, sustainability isn’t just operational, it’s strategic. By embedding these rules into our know-how roadmap, we assist pharmaceutical corporations obtain environmental objectives whereas sustaining productiveness and regulatory alignment. This strategy ensures long-term stability and a future-ready manufacturing mannequin.
Which latest improvements in product improvement or course of optimization have had the broadest affect on value, high quality, or speed-to-market in manufacturing operations?
At IMA Energetic, latest innovation has centered on steady processes and specialised functions that ship measurable advantages in effectivity and high quality. Our Steady Direct Compression (CDC) know-how gives a lean and versatile tableting resolution that, mixed with PAT [process analytical technology] instruments, allows speedy achievement of a state of management and eliminates waste throughout start-up and shutdown. Alongside CDC, our Steady Coaters full the vary for high-throughput coating, making certain constant efficiency for giant batches. In capsule filling, we’ve launched devoted options for dry powder inhalers (DPIs), assembly rising demand for respiratory therapies with precision and reliability.
Probably the most transformative innovation is modularity. Modular pill compression platforms ship aggressive benefits globally by enabling speedy format modifications, scalability for gradual funding, and seamless integration with Pharma 4.0 ideas. They enhance operational effectivity and sustainability whereas adapting to numerous market wants.
DOMINA embodies this imaginative and prescient. Its plug-and-play structure, patented Dynamicam filling system, and adaptive automation guarantee precision and suppleness. Mixed with brushless motorization and servo-assisted changeovers, DOMINA minimizes downtime and maximizes high quality, serving to producers minimize prices, pace up manufacturing, and embrace the way forward for good manufacturing.
What position do synthetic intelligence (AI) and digital applied sciences play in enhancing manufacturing effectivity, and what are some unresolved obstacles to full adoption?
AI and digitalization are reworking pharmaceutical manufacturing, and at IMA Energetic we apply them in a sensible, process-driven manner. Our machines combine superior algorithms for real-time optimization, predictive analytics, and preventive diagnostics. This permits automated adjustment of manufacturing settings based mostly on sensor knowledge, whereas constantly monitoring working circumstances to detect anomalies early.
Digital applied sciences additionally improve usability: guided interfaces and superior diagnostics simplify operator selections and cut back human error. These programs enhance product high quality, decrease waste, and improve course of stability.
Nonetheless, adoption faces important challenges: balancing superior automation with intuitive usability for operators, making certain high-quality and built-in datasets, and assembly regulatory calls for for explainable AI and knowledge integrity. Cultural and ability gaps additionally persist, requiring sturdy coaching and alter administration.
What are the opposite largest challenges that you just see in your market that must be addressed within the coming 12 months?
Pharmaceutical manufacturing faces a convergence of challenges that transcend know-how. Regulatory complexity is rising, with international frameworks demanding stricter compliance and knowledge integrity.
Provide chain resilience stays a precedence, as corporations work to strengthen continuity and suppleness in a dynamic international state of affairs, whereas sustainability and environmental transparency have gotten non-negotiable priorities. Digitalization introduces its personal challenges: integrating legacy programs, making certain cybersecurity, and balancing superior automation with intuitive usability for operators. Lastly, the rising want for specialised expertise requires steady coaching and cultural transformation.
These challenges aren’t obstacles; they’re catalysts for innovation. They push us to design smarter applied sciences, strengthen international service networks, and create options that mix flexibility, compliance, and sustainability. At IMA Energetic, we see this as a possibility to steer the transition towards a extra resilient and future-ready pharmaceutical ecosystem.
How are you addressing these?
We reply to market challenges with a complete technique that goes far past gear provide. We ship full options, from standalone machines to completely built-in strains, combining engineering, automation, and software program to fulfill the evolving wants of pharmaceutical producers. Innovation and digitalization are on the core of our roadmap: we embed Pharma 5.0 rules into each know-how, leveraging real-time monitoring, predictive analytics, and digital twins to optimize processes, cut back downtime, and guarantee knowledge integrity. Steady manufacturing displays our dedication to future-ready manufacturing fashions.
Equally vital is our international help community and Competence Facilities, which speed up innovation by trials, scale-up, and course of optimization, whereas offering coaching and lifecycle help to ensure operational continuity. Sustainability additionally drives our imaginative and prescient: energy-efficient programs, modular architectures, and clever management options decrease waste and environmental affect whereas adapting to numerous regional necessities.
By integrating know-how, digital transformation, and repair excellence, we assist pharmaceutical corporations flip complexity into alternative, constructing environment friendly, compliant, and sustainable manufacturing ecosystems worldwide.
Concerning the interviewee
Luca Cavazzini is Gross sales & Advertising Director at IMA Energetic, a division of IMA Pharma, who’s mission is to ship superior applied sciences for oral strong dose manufacturing, combining mechanical excellence with digital innovation. Luca’s position focuses on aligning market wants with our technological roadmap, creating options that anticipate regulatory, operational, and sustainability challenges. Past machines, the corporate goals to offer built-in programs and companies that assist pharmaceutical corporations speed up time-to-market whereas making certain high quality and compliance.
Leave a Reply